Alpha Teknova (TKNO) Research & Development (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Research & Development of $2.1 million for Q1 2026, up 285.51% year-over-year from $552000.0 in Q1 2025, and up 177.02% quarter-over-quarter from -$2.8 million in Q4 2025.
Alpha Teknova (TKNO) Research & Development (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Research & Development for 7 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 285.51% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $488000.0 (down 88.36% YoY), while the FY2025 annual figure was $2.2 million, down 65.24% from the prior year.
- Research & Development grew to $2.1 million in Q1 2026 per TKNO's latest filing, from -$2.8 million in the prior quarter.
- Across five years, Research & Development topped out at $2.4 million in Q4 2023 and bottomed at -$2.8 million in Q4 2025.
- Historically, Research & Development has averaged $1.2 million across 5 years, with a median of $1.5 million in 2024.
- Annual changes were most pronounced in 2025 — Research & Development tumbled 277.46% — and 2026, when it surged 285.51%.
- Alpha Teknova's Research & Development stood at $1.1 million in 2022, then soared by 109.69% to $2.4 million in 2023, then tumbled by 35.15% to $1.6 million in 2024, then sank by 277.46% to -$2.8 million in 2025, then jumped by 177.02% to $2.1 million in 2026.
- Business Quant data shows TKNO's Research & Development at $2.1 million in Q1 2026, -$2.8 million in Q4 2025, and $542000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | 2.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.12 Mn |
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | -2.76 Mn |
| Sep 30, 2025 | 542,000.00 |
| Jun 30, 2025 | 581,000.00 |
| Mar 31, 2025 | 552,000.00 |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 627,000.00 |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 860,000.00 |
| Dec 31, 2023 | 2.40 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Dec 31, 2022 | 1.15 Mn |
| Sep 30, 2022 | 1.93 Mn |
| Jun 30, 2022 | 1.93 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 855,000.00 |
| Sep 30, 2021 | 1.37 Mn |